209 related articles for article (PubMed ID: 35702913)
21. Geoepidemiology of autoimmune rheumatic diseases.
Shapira Y; Agmon-Levin N; Shoenfeld Y
Nat Rev Rheumatol; 2010 Aug; 6(8):468-76. PubMed ID: 20567251
[TBL] [Abstract][Full Text] [Related]
22. Circulating Calprotectin (cCLP) in autoimmune diseases.
Manfredi M; Van Hoovels L; Benucci M; De Luca R; Coccia C; Bernardini P; Russo E; Amedei A; Guiducci S; Grossi V; Bossuyt X; Perricone C; Infantino M
Autoimmun Rev; 2023 May; 22(5):103295. PubMed ID: 36781037
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of rheumatic diseases in central Greece: a population survey.
Anagnostopoulos I; Zinzaras E; Alexiou I; Papathanasiou AA; Davas E; Koutroumpas A; Barouta G; Sakkas LI
BMC Musculoskelet Disord; 2010 May; 11():98. PubMed ID: 20504294
[TBL] [Abstract][Full Text] [Related]
24. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
[TBL] [Abstract][Full Text] [Related]
25. Outbreak of autoimmune disease in silicosis linked to artificial stone.
Shtraichman O; Blanc PD; Ollech JE; Fridel L; Fuks L; Fireman E; Kramer MR
Occup Med (Lond); 2015 Aug; 65(6):444-50. PubMed ID: 26070814
[TBL] [Abstract][Full Text] [Related]
26. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study.
Ng KH; Chen DY; Lin CH; Chao WC; Chen YM; Chen YH; Huang WN; Hsieh TY; Lai KL; Tang KT; Chen HH
Semin Arthritis Rheum; 2020 Oct; 50(5):840-845. PubMed ID: 32896697
[TBL] [Abstract][Full Text] [Related]
27. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
[TBL] [Abstract][Full Text] [Related]
29. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
Baglaenko Y; Chang NH; Johnson SR; Hafiz W; Manion K; Ferri D; Noamani B; Bonilla D; Rusta-Sellehy S; Lisnevskaia L; Silverman E; Bookman A; Landolt-Marticorena C; Wither J
Arthritis Res Ther; 2018 Nov; 20(1):264. PubMed ID: 30486869
[TBL] [Abstract][Full Text] [Related]
30. Erasmus Syndrome: Association of Silicosis and Systemic Sclerosis.
Sharma RK; Sharma AK; Sharma A
Indian Dermatol Online J; 2018; 9(3):185-187. PubMed ID: 29854640
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of fibromyalgia syndrome in different rheumatic diseases: Relation to disease activity and quality of life.
El-Rabbat M S; Mahmoud NK; Gheita TA
Reumatol Clin (Engl Ed); 2018; 14(5):285-289. PubMed ID: 28411133
[TBL] [Abstract][Full Text] [Related]
32. Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico.
Munguía-Realpozo P; Mendoza-Pinto C; Etchegaray-Morales I; Solis-Poblano JC; Ayón-Aguilar J; Ramírez-Lara E; Orbe-Sosa J; Méndez-Martínez S; García-Carrasco M
Rheumatol Int; 2023 Sep; 43(9):1611-1619. PubMed ID: 37349634
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
Jorge AM; Lu N; Keller SF; Rai SK; Zhang Y; Choi HK
J Rheumatol; 2018 Dec; 45(12):1689-1695. PubMed ID: 30173155
[TBL] [Abstract][Full Text] [Related]
34. Causes of mortality associated with autoimmune rheumatic disease in a referral hospital.
Leonardo H; Carrascosa M; Arreola R; Herrera-Méndez M
Reumatol Clin (Engl Ed); 2022 May; 18(5):304-308. PubMed ID: 34531169
[TBL] [Abstract][Full Text] [Related]
35. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases.
Bernatsky S; Linehan T; Hanly JG
J Rheumatol; 2011 Aug; 38(8):1612-6. PubMed ID: 21532057
[TBL] [Abstract][Full Text] [Related]
36. Silica exposure and autoimmune diseases.
Steenland K; Goldsmith DF
Am J Ind Med; 1995 Nov; 28(5):603-8. PubMed ID: 8561170
[TBL] [Abstract][Full Text] [Related]
37. Human Papiloma Virus Screening: Evaluation Of Testing And Surveillance In Rheumatoid Arthritis, Psoriatic Arthritis And Systemic Lupus Erythematosus.
Vidal Alejandre B; Tovar Sugrañes E; López Poza R; Andrés M; Martínez-Vidal MP
Reumatol Clin (Engl Ed); 2020 Jul; ():. PubMed ID: 32709510
[TBL] [Abstract][Full Text] [Related]
38. Connective tissue disease and silicosis.
Rosenman KD; Moore-Fuller M; Reilly MJ
Am J Ind Med; 1999 Apr; 35(4):375-81. PubMed ID: 10086214
[TBL] [Abstract][Full Text] [Related]
39. Study of familial aggregation of autoimmune rheumatic diseases in Asian Indian patients with systemic lupus erythematosus.
Ganapati A; Arunachal G; Arya S; Shanmugasundaram D; Jeyaseelan L; Kumar S; Danda S; Danda D
Rheumatol Int; 2019 Dec; 39(12):2053-2060. PubMed ID: 31263994
[TBL] [Abstract][Full Text] [Related]
40. Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus.
Vidal Alejandre B; Tovar Sugrañes E; López Poza R; Andrés M; Martínez-Vidal MP
Reumatol Clin (Engl Ed); 2021 Nov; 17(9):494-498. PubMed ID: 34756309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
